Saturday, October 10, 2015: 2:00 PM-3:30 PM
Room: 31--ABC
Learning Objectives:
At the conclusion of this session, participants will be able to:
- discuss updates on the clinical management of tuberculous meningitis and nontubercular mycobacterial disease
- assess how recent research on the pathophysiology of mycobacterial diseases can impact medical management
- explain host-directed therapies and personalized medicine in the context of mycobacterial disease
- describe mycobacterial evasion strategies that have thwarted classical vaccine strategies and how these might be overcome
Target Audience: Scientists, Vaccinologists, Researchers, Public health practitioners, Pharmacists, Nurses, Microbiologists, Members-in-training, Lab personnel, Investigators, Infectious diseases physicians, Infectious diseases pediatricians, Infection preventionists, Hospital epidemiologists, HIV specialists, HIV clinicians, Healthcare workers, Fellows, Epidemiologists, Clinicians, Academicians
Tracks: Pediatric ID, Investigative ID, HIV-STD-TB, Global ID, Adult ID, Trainee
Moderators:
Joel Ernst, MD, FIDSA, New York University School of Medicine
and
Lalita Ramakrishnan, MD, PhD, University of Cambridge
Presentations:
2:00 PM
New Insights into Genomics and Genetics of Nontuberculous Mycobacteria and their Therapeutic Implications
Andres Floto, MD, PhD, FRCP
Andres Floto, MD, PhD, FRCP
3:00 PM
Understanding and Countering Mycobacterial Host Evasion Strategies to Make an Effective TB Vaccine
Kevin Urdahl, MD, PhD
Kevin Urdahl, MD, PhD
CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM
ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE
ACPE Number: 0221-9999-15-202-L01-P
Disclosures:
J. Ernst,
None
See more of: Symposium